Corporate DisclosureCENTRALPHL
CENTRALPHL Corporate Disclosure — 28 February 2017
Announcement summary
- What happened
- CENTRALPHL published a corporate disclosure on 28 February 2017. Read the full announcement for details.
- Company
- Central Pharmaceuticals Limited
- Announcement published
Original announcement
In connection with the instruction for closure of production and distribution of Penicillin, Cephalosporin, Steroid, and cancer antidote of 28 medicine companies within next 3 days, the Company informed the following: As necessary set up for manufacturing of Penicillin and Cephalosporin type medicine was not completed, Drugs Administrative Authority suspended the manufacturing of stated medicine (Ref. No. DA/ML-060/05/2341 dated 20.02.2012) (cont.1)
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616acf0d5a6b00004005ff25
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from CENTRALPHL
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.